Matauro LLC Grows Stock Holdings in UnitedHealth Group Incorporated $UNH

Matauro LLC grew its holdings in UnitedHealth Group Incorporated (NYSE:UNH) by 169.3% during the 2nd quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The fund owned 2,704 shares of the healthcare conglomerate’s stock after acquiring an additional 1,700 shares during the period. Matauro LLC’s holdings in UnitedHealth Group were worth $843,000 at the end of the most recent quarter.

Several other large investors have also made changes to their positions in the business. Triad Wealth Partners LLC boosted its holdings in shares of UnitedHealth Group by 11.0% in the 2nd quarter. Triad Wealth Partners LLC now owns 2,591 shares of the healthcare conglomerate’s stock valued at $808,000 after acquiring an additional 257 shares during the last quarter. Mirae Asset Global Investments Co. Ltd. boosted its holdings in UnitedHealth Group by 15.8% during the second quarter. Mirae Asset Global Investments Co. Ltd. now owns 154,874 shares of the healthcare conglomerate’s stock worth $48,316,000 after buying an additional 21,177 shares in the last quarter. Patriot Financial Group Insurance Agency LLC boosted its holdings in UnitedHealth Group by 42.5% during the second quarter. Patriot Financial Group Insurance Agency LLC now owns 5,312 shares of the healthcare conglomerate’s stock worth $1,657,000 after buying an additional 1,583 shares in the last quarter. ASR Vermogensbeheer N.V. boosted its holdings in UnitedHealth Group by 18.8% during the second quarter. ASR Vermogensbeheer N.V. now owns 208,367 shares of the healthcare conglomerate’s stock worth $65,001,000 after buying an additional 33,038 shares in the last quarter. Finally, Platinum Investment Management Ltd. purchased a new stake in UnitedHealth Group during the second quarter worth $286,000. 87.86% of the stock is owned by hedge funds and other institutional investors.

Analyst Upgrades and Downgrades

A number of brokerages recently issued reports on UNH. Robert W. Baird reissued an “underperform” rating and set a $198.00 price target (down from $312.00) on shares of UnitedHealth Group in a report on Thursday, July 31st. Bank of America upped their price objective on shares of UnitedHealth Group from $290.00 to $325.00 and gave the stock a “neutral” rating in a research report on Monday, August 18th. Royal Bank Of Canada reduced their price objective on shares of UnitedHealth Group from $355.00 to $286.00 and set an “outperform” rating for the company in a research report on Wednesday, July 30th. Sanford C. Bernstein upped their price objective on shares of UnitedHealth Group from $337.00 to $379.00 and gave the stock an “outperform” rating in a research report on Friday, September 5th. Finally, Barclays upped their price objective on shares of UnitedHealth Group from $337.00 to $352.00 and gave the stock an “overweight” rating in a research report on Thursday, September 4th. Sixteen investment analysts have rated the stock with a Buy rating, six have given a Hold rating and three have given a Sell rating to the company’s stock. According to MarketBeat.com, the company presently has a consensus rating of “Moderate Buy” and an average target price of $358.95.

UnitedHealth Group Price Performance

UnitedHealth Group stock opened at $353.26 on Friday. UnitedHealth Group Incorporated has a 12-month low of $234.60 and a 12-month high of $630.73. The stock has a market cap of $319.94 billion, a P/E ratio of 15.31, a PEG ratio of 2.27 and a beta of 0.47. The company has a 50-day moving average price of $306.25 and a 200 day moving average price of $356.57. The company has a current ratio of 0.85, a quick ratio of 0.85 and a debt-to-equity ratio of 0.73.

UnitedHealth Group (NYSE:UNH) last released its quarterly earnings data on Tuesday, July 29th. The healthcare conglomerate reported $4.08 earnings per share (EPS) for the quarter, missing the consensus estimate of $4.45 by ($0.37). UnitedHealth Group had a return on equity of 23.32% and a net margin of 5.04%.The firm had revenue of $111.62 billion for the quarter, compared to analyst estimates of $111.75 billion. During the same quarter in the previous year, the business posted $6.80 earnings per share. UnitedHealth Group’s revenue for the quarter was up 12.9% on a year-over-year basis. UnitedHealth Group has set its FY 2025 guidance at 16.000- EPS. Sell-side analysts anticipate that UnitedHealth Group Incorporated will post 29.54 earnings per share for the current year.

UnitedHealth Group Dividend Announcement

The company also recently disclosed a quarterly dividend, which was paid on Tuesday, September 23rd. Investors of record on Monday, September 15th were given a dividend of $2.21 per share. This represents a $8.84 annualized dividend and a yield of 2.5%. The ex-dividend date was Monday, September 15th. UnitedHealth Group’s dividend payout ratio (DPR) is presently 38.30%.

UnitedHealth Group Company Profile

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.